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Abstract: Background: Alzheimer disease (AD) is a leading cause of global burden with great impact on
societies. Although research is working intensively on promising therapy, the problem remains up-to-date.
Among the various proposed hypotheses regarding causality and therapy, emerging evidence supports the
hypothesis that gastrointestinal microbiota through the so-called ’gut-brain axis’ interacts with immune
system and brain and shape the balance between homeostasis and disease; the involvement of gastroin-
testinal microbiota in the pathophysiology of AD is less defined, even though the role of ’gut-brain axis’
has been well verified for other neurodegenerative conditions.Methods: We performed a systematic re-
view of PubMed/MEDLINE database from 1st January 1990 to 17th October 2018, to investigate the
accessible literature regarding possible association between AD and gastrointestinal microbiota. Inclusion
criteria were available full text in English language, original clinical papers implicating AD patients and
any sort of gastrointestinal microbiota.Results: Through our query, an initial number of 241 papers has
been identified. After removing duplicates and through an additional manual search, twenty-four papers
met our inclusion criteria. The great majority of eligible publications supported a possible connection
between AD and gastrointestinal microbiota. The most common investigated microorganism was Heli-
cobacter pylori.Conclusion: Our own systematic review, showed a possible association between AD and
gastrointestinal microbiota mainly including Helicobacter pylori, and thus further research is required for
substantiation of causality as well as for the establishment of promising novel therapies.
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Table 2.  Proposed mechanism of action along with the type of investigation and implicated microbiota 
Authors (Year) Type of microbiota Proposed mechanism of 
action 
Type of investigation Main Outcome 
Akbari et al. (2016) Lactobacillus 
acidophilus, L. casei, L. 
fermentum and 
Bifidobacterium bifidum  
Probiotics might adjust brain activity 
through contributing in 
neurotransmitter  synthesis or receptor 
expression  
 
Assessment of  the effects of probiotic 
supplementation on cognitive function and 
metabolic status 
+ 





AD patients might have different 
microbiota populations and 
homeostasis imbalance due to plethora 
of reasons and promote release of 
rhamnolipids through inflammatory 
cascade 
Investigation of  a) temporary presence of 
ramnolipids in blood serum b) comparison 
of their concentration in blood serum and 
CSF in AD, MCI and control subjects  
- 
Araos et al. (2018) Clostridium difficile and 
GMB 
ΝΜ Assessment of the diversity and 
composition of the gut microbiota among 
LTCF residents with advanced dementia 
colonized with Clostridium difficile 
- 
Beydoun et al. (2013) HP 1.endothelial dysfunction due to 
hyperhomocysteinemia 2.apoptosis  
(cell-mediated), overexpression of 
Nitric oxide or molecular mimicry of 
host structures,  3. Inflammatory 
responses, 4. BBB disruption with 
amyloid deposition 5. Cytotoxic 
strains influence the  development of 
atherosclerosis- atherosclerotic stroke 
6. release of vasoactive substances or 
molecular mimicry contribute to 
hypertensive disease which mediates 
it’s effect on AD 
Examination of the  associations between 
serum measures of HP infection and 
cognitive performance and  exploration if 
those associations were sex and/or race-
specific 
- 
Bu et al. (2015) HP, CP, CMV, HSV-1, 
Borrelia burgdorferi Ab 
Infection triggered autoantibodies with 
subsequent synaptic and neuronal 
dysfunction 
examination of the association between 
infectious burden AD 
- 
Cattaneo et al. (2017) GMBS immune and inflammatory responses 
in the brain leading to 
neurodegeneration 
investigation of the possible role of the 
GMB in AD pathogenesis by studying the 
association of brain amyloidosis with GMB 
taxa with pro- and anti-inflammatory 
- 
activity; and peripheral inflammation in 
cognitively impaired patients. 
Farhad et al. (2014) Peridontal microbiota Tumor necrosis factor-α mediated Evaluation of the effect of chronic 
periodontitis on serum levels of tumor 
necrosis factor-α in AD 
- 
Ide et al. (2016) Porphyromonas 
gingivalis Ab 
Periodontitis/antibodies to periodontal 
bacterial flora are associated with an 
increase  in serum CRP; TNFα and 
TNFα/IL10 ratios in individuals with 
AD. 
determination if periodontitis in AD is 
associated with both increased dementia 
severity and cognitive decline, and an 
increased systemic pro inflammatory state 
- 
Katan et al. (2013) HP, CP,CMV, HSV-1, 
HSV-2 
1. Chronic infection and 
atherosclerosis  2. direct toxic effect of 
some neurotropic agents in the 
development of cognitive impairment 
infectious burden, a composite serologic 
measure of exposure to common pathogens  
associated with vascular risk in the 
prospective Northern Manhattan Study, 
would also be associated with cognition 
- 
Kountouras et al. 
(2006) 
HP 1. Promotion of platelet and platelet–
leukocyte aggregation. 
2. immune mediated (humoral and 
cellular)   
3. Production of reactive oxygen 
metabolites and circulating lipid 
association between Hp infection and AD 




Kountouras et al. 
(2007) 
HP evaluation of HP infection, by histology 
in a Greek MCI cohort 
 
- 
Kountouras et al. 
(2009) 
HP examination of the levels of anti-HP-
specific IgG antibodies in the cerebrospinal 
fluid  and serum of AD patients, compared 




Kountouras et al. 
(2009) 
HP peroxides  
4.apoptosis   
5.Hyperhomocysteinemia and 
atherothrombotic disorders 
6. fibrin is a mediator of inflammation 
and may accelerate neurovascular 
damage in AD. 
 
Assessment of the effect of Hp eradication 




Kountouras et al. 
(2010) 
HP Hypothesis that eradication of Hp infection 
could improve survival in a Greek cohort of 




Toxoplasma gondii  NΜ Investigation of  the correlation between 
Toxoplasma as an etiologic agent in the 
progress of AD 
N 
Malaguarnera et al. 
(2004) 
HP hyperhomocysteinemia and Hp-IgG 
mediated brain inflammation  
Determination whether chronic HP 
infection might play a role in AD 
 




ΝΜ Discussion of co-occurring neuroborreliosis 
and AD through a case report 
N 
Nägga et al. (2003) HP Antibodies NM Investigation of association among 
dementia disorders, cobalamin and/or folate 
deficiency as well as gastritis 
N 
Noble et al. (2014) PM atherogenesis-stroke,  endothelial 
dysfunction with white matter 
hyperintensities or  association with 
systemic inflammation 
Association with APOE 
Examination of serum IgG to periodontal 





HP Hp associated neuronal loss Comparison of  cognitive impairment, 
neuroinflammation, and cerebrovascular 
lesion load in a group of AD patients 




HP 1. Homocysteinemia  and endothelial 
injury  2.systemic and neuro-CSF 
inflammation 
Determination whether HP infection was 
associated with dementia and risk of 
developing dementia in elderly adults living 
in the community 
- 
Shiota et al. (2011) HP NM Prevalence of HP infection was examined 
among AD patients in Japan 
N 
Sparks Stein et al. 
(2012) 
PP immune mediated Comparison of serum antibody levels (to 
bacteria of periodontal disease) between 
participants who eventually converted to 
Alzheimer’s disease   and control subjects 
- 
Zhan et al. (2016) LPS & E coli K99 pili 
protein 
microbial proteins contribute to vessel, 
ependymal  and white matter injury 
Determination whether Gram-negative 
bacterial molecules are associated with 
Alzheimer disease neuropathology 
- 
Table 2 legend Ab: Antibodies, AD: Alzheimer’s disease, APOE; apolipoprotein ε4, CMV: cytomegalovirus, CP: Chlamydophila (Chlamydia) pneumonia, GMB: gut 
microbiota; Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, Bacteroides, Campylobacter, Corynebacterium, Escherichia/Shigella, Akkermansia, Dermabacter, 
Romboutsia, Meiothermus, Peptoclostridium and Ruminococcaceae spp. GMBS: gut microbiota in stool; Escherichia/Shigella, Pseudomonas aeruginosa, Eubacterium rectale, 
Eubacterium hallii, Faecalibacterium prausnitzii, and Bacteroides fragilis, HP: Helicobacter pylori, HSV-1,2: Herpes simplex virus 1 and 2, LPS: Lipopolysaccharide, LTCF: 
long-term care facility, MCI: mild cognitice impairment, PM: periodontal microbiota; Porphyromonas gingivalis, Tannerella forsythia, Actinobacillus actinomycetemcomitans 
Y4, Treponema denticola, Campylobacter rectus, Eubacterium nodatum, and Actinomyces naeslundii genospecies-2, PP: Periodontal pathogens; Aggregatibacter 
actinomycetemcomitans, porphyromonas gingivalis, Campylobacter rectus, Treponema denticola,  Fusobacterium nuclueatum, Tanerella forsythia, Prevotella intermedia, 
Outcome interprentation: (-): microbiota contributes to deterioration of AD, (+): microbiota might improve AD, (N): no association 
 
